Clinical Trial Update: Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients [Phase 2]

View source ↗

Summary

Phase 2a study evaluating IcBD-01 enema in active ulcerative colitis is ongoing, status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• IcBD-01 enema

Snippet

Sponsor: CannaMore Biotechs | Conditions: Ulcerative Colitis | Phase 2 | Status: UNKNOWN